Attached files
| file | filename |
|---|---|
| EX-3.1 - EX-3.1 - Cytek Biosciences, Inc. | d80783dex31.htm |
| EX-3.3 - EX-3.3 - Cytek Biosciences, Inc. | d80783dex33.htm |
| EX-10.1 - EX-10.1 - Cytek Biosciences, Inc. | d80783dex101.htm |
| EX-10.2 - EX-10.2 - Cytek Biosciences, Inc. | d80783dex102.htm |
| EX-10.3 - EX-10.3 - Cytek Biosciences, Inc. | d80783dex103.htm |
| EX-10.9 - EX-10.9 - Cytek Biosciences, Inc. | d80783dex109.htm |
| EX-10.11 - EX-10.11 - Cytek Biosciences, Inc. | d80783dex1011.htm |
| EX-10.13 - EX-10.13 - Cytek Biosciences, Inc. | d80783dex1013.htm |
| EX-10.14 - EX-10.14 - Cytek Biosciences, Inc. | d80783dex1014.htm |
| S-1 - REGISTRATION STATEMENT ON FORM S-1 - Cytek Biosciences, Inc. | d80783ds1.htm |
| EX-10.12 - EX-10.12 - Cytek Biosciences, Inc. | d80783dex1012.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated April 21, 2021, relating to the financial statements of Cytek Biosciences, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
San Jose, California
July 2, 2021